• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Reynolds Paula Rosput bought $44,134 worth of Ordinary Shares (100 units at $441.34), increasing direct ownership by 75% to 233 units (SEC Form 4)

    12/12/24 2:22:03 PM ET
    $LIN
    Major Chemicals
    Industrials
    Get the next $LIN alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Reynolds Paula Rosput

    (Last) (First) (Middle)
    C/O LINDE PLC
    FORGE, 43 CHURCH STREET WEST

    (Street)
    WOKING SURREY X0 GU216HT

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    LINDE PLC [ LIN ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    12/12/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Ordinary Shares 12/12/2024 P 100 A $441.34 233 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Deferred Stock Units (1) (2) (2) Ordinary Shares 17.104 17.104 D
    Restricted Stock Units (3) (3) (3) Ordinary Shares 477 477 D
    Explanation of Responses:
    1. Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.
    2. Deferred stock units acquired under the Linde Non-Employee Director Deferral Plan ("Plan"). The deferred stock units will payout in Linde plc Ordinary Share on a one-for-one basis in accordance with the Plan.
    3. The Restricted Stock Units ("RSU") shall vest in full and payout in Ordinary Shares on a one-for-one basis one year after the March 7, 2024 date of grant, provided that the awardee serves on the Linde plc Board of Directors continuously through the vesting date, except under certain circumstances in which a pro-rata payout may be made.
    Remarks:
    Anthony M. Pepper as attorney-in-fact 12/12/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $LIN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LIN

    DatePrice TargetRatingAnalyst
    6/13/2025$576.00Outperform
    RBC Capital Mkts
    1/13/2025Hold → Buy
    TD Cowen
    4/18/2024$510.00Neutral → Buy
    Mizuho
    4/10/2024$475.00 → $500.00Buy → Neutral
    Citigroup
    3/27/2024$482.00 → $510.00Buy → Neutral
    UBS
    3/1/2024Peer Perform
    Wolfe Research
    2/16/2024$395.00 → $455.00Market Perform
    TD Cowen
    1/22/2024$429.00Buy → Hold
    Stifel
    More analyst ratings

    $LIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • RBC Capital Mkts initiated coverage on Linde plc with a new price target

      RBC Capital Mkts initiated coverage of Linde plc with a rating of Outperform and set a new price target of $576.00

      6/13/25 7:49:18 AM ET
      $LIN
      Major Chemicals
      Industrials
    • Linde plc upgraded by TD Cowen

      TD Cowen upgraded Linde plc from Hold to Buy

      1/13/25 8:21:47 AM ET
      $LIN
      Major Chemicals
      Industrials
    • Linde plc upgraded by Mizuho with a new price target

      Mizuho upgraded Linde plc from Neutral to Buy and set a new price target of $510.00

      4/18/24 7:34:08 AM ET
      $LIN
      Major Chemicals
      Industrials